Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease.

Takuma IsshikiHiroshige ShimizuSusumu SakamotoAkira YamasakiShion MiyoshiYasuhiko NakamuraSakae HommaKazuma Kishi

Published in: ERJ open research (2022)

Serum ATX levels were significantly higher in patients with fibrosing ILD compared with healthy controls, and this was associated with disease progression and outcome. This suggests the potential of serum ATX as a promising biomarker for the treatment of fibrosing ILD.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
chronic obstructive pulmonary disease
liver failure
respiratory failure
combination therapy
human health
acute respiratory distress syndrome